The Full Story
About
Atzeyo Biosensors is revolutionizing cancer care by transforming early diagnosis and ongoing monitoring for patients. Our innovative point-of-care technology enables physicians to receive critical diagnostic results in real-time, right in the office. This eliminates the delays associated with traditional laboratory testing and empowers doctors to make faster, more informed decisions about patient care.
Our proof-of-concept studies have demonstrated that Atzeyo’s biosensors offer superior detection capabilities compared to PCR testing. This advanced technology is not only more accurate but also more accessible. Designed as an easy-to-use, cost-effective device, it brings cutting-edge diagnostic capabilities to more healthcare settings, making it feasible for widespread adoption in clinics and hospitals alike.
Over the past seven years, Atzeyo has significantly de-risked the development of our product. With the support of over $17 million in grants and more than 100 peer-reviewed publications, we have rigorously tested and refined our biosensors, ensuring their reliability and effectiveness. This robust foundation demonstrates our commitment to scientific excellence and patient care, positioning Atzeyo Biosensors as a leader in the future of cancer diagnostics. We are dedicated to enhancing patient outcomes and supporting healthcare providers with real-time, actionable data.
Mission
Our Mission is to transform the cancer patient journey. Delays of 2-3 months before seeing an oncologist and average clinic visits of 278 minutes is a heavy worry and wait burden for the average patient.
Vision
Cancer patients worry and wait time dramatically reduced or eliminated. Long delays to see an oncologist, multiple unnecessary physician and lab visits gone. Physicians empowered by definitive results in less than 30 minutes.